193 related articles for article (PubMed ID: 23299308)
1. Artificial antigen presenting cell (aAPC) mediated activation and expansion of natural killer T cells.
East JE; Sun W; Webb TJ
J Vis Exp; 2012 Dec; (70):. PubMed ID: 23299308
[TBL] [Abstract][Full Text] [Related]
2. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
[TBL] [Abstract][Full Text] [Related]
3. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
Dasgupta S; Kumar V
Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
[TBL] [Abstract][Full Text] [Related]
4. A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse Model.
Wen X; Kim S; Xiong R; Li M; Lawrenczyk A; Huang X; Chen SY; Rao P; Besra GS; Dellabona P; Casorati G; Porcelli SA; Akbari O; Exley MA; Yuan W
J Immunol; 2015 Aug; 195(4):1459-69. PubMed ID: 26157173
[TBL] [Abstract][Full Text] [Related]
5. Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma.
Wu L; Yun Z; Tagawa T; De la Maza L; Wu MO; Yu J; Zhao Y; de Perrot M
Cancer Immunol Immunother; 2014 Dec; 63(12):1285-96. PubMed ID: 25183171
[TBL] [Abstract][Full Text] [Related]
6. Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent Manner.
Takami M; Aoki T; Nishimura K; Tanaka H; Onodera A; Motohashi S
Cancer Res Commun; 2024 Feb; 4(2):446-459. PubMed ID: 38319156
[TBL] [Abstract][Full Text] [Related]
7. Ox-LDL-induced CD80
Wang Y; Zou Y; Jiang Q; Li W; Chai X; Zhao T; Liu S; Yuan Z; Yu C; Wang T
Am J Physiol Cell Physiol; 2024 Jun; 326(6):C1563-C1572. PubMed ID: 38586879
[TBL] [Abstract][Full Text] [Related]
8. Sterile activation of invariant natural killer T cells by ER-stressed antigen-presenting cells.
Bedard M; Shrestha D; Priestman DA; Wang Y; Schneider F; Matute JD; Iyer SS; Gileadi U; Prota G; Kandasamy M; Veerapen N; Besra G; Fritzsche M; Zeissig S; Shevchenko A; Christianson JC; Platt FM; Eggeling C; Blumberg RS; Salio M; Cerundolo V
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23671-23681. PubMed ID: 31690657
[TBL] [Abstract][Full Text] [Related]
9. The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions.
Macho-Fernandez E; Brigl M
Front Immunol; 2015; 6():362. PubMed ID: 26284062
[TBL] [Abstract][Full Text] [Related]
10. The biliary epithelium presents antigens to and activates natural killer T cells.
Schrumpf E; Tan C; Karlsen TH; Sponheim J; Björkström NK; Sundnes O; Alfsnes K; Kaser A; Jefferson DM; Ueno Y; Eide TJ; Haraldsen G; Zeissig S; Exley MA; Blumberg RS; Melum E
Hepatology; 2015 Oct; 62(4):1249-59. PubMed ID: 25855031
[TBL] [Abstract][Full Text] [Related]
11. Detection of Mouse Type I NKT (iNKT) Cells by Flow Cytometry.
Joshi V; Terabe M
Methods Mol Biol; 2021; 2388():87-99. PubMed ID: 34524664
[TBL] [Abstract][Full Text] [Related]
12. Targeting Natural Killer T Cells in Solid Malignancies.
Ingram Z; Madan S; Merchant J; Carter Z; Gordon Z; Carey G; Webb TJ
Cells; 2021 May; 10(6):. PubMed ID: 34072042
[TBL] [Abstract][Full Text] [Related]
13. Conservation of molecular and cellular phenotypes of invariant NKT cells between humans and non-human primates.
Yu KKQ; Wilburn DB; Hackney JA; Darrah PA; Foulds KE; James CA; Smith MT; Jing L; Seder RA; Roederer M; Koelle DM; Swanson WJ; Seshadri C
Immunogenetics; 2019 Jul; 71(7):465-478. PubMed ID: 31123763
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells.
Girardi E; Zajonc DM
Immunol Rev; 2012 Nov; 250(1):167-79. PubMed ID: 23046129
[TBL] [Abstract][Full Text] [Related]
15. CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections.
Chung BK; Priatel JJ; Tan R
Front Immunol; 2015; 6():312. PubMed ID: 26161082
[TBL] [Abstract][Full Text] [Related]
16. Complementary approaches to study NKT cells in cancer.
Berzofsky JA; Olkhanud PB; Terabe M
Methods Enzymol; 2020; 631():371-389. PubMed ID: 31948558
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic factors and CD1d1 but not CD1d2 expression levels control invariant natural killer T cell subset differentiation.
Amable L; Ferreira Martins LA; Pierre R; Do Cruseiro M; Chabab G; Sergé A; Kergaravat C; Delord M; Viret C; Jaubert J; Liu C; Karray S; Marie JC; Irla M; Georgiev H; Clave E; Toubert A; Lucas B; Klibi J; Benlagha K
Nat Commun; 2023 Dec; 14(1):7922. PubMed ID: 38040679
[TBL] [Abstract][Full Text] [Related]
18. Analyzing antigen recognition by Natural Killer T cells.
Zeissig S; Olszak T; Melum E; Blumberg RS
Methods Mol Biol; 2013; 960():557-572. PubMed ID: 23329514
[TBL] [Abstract][Full Text] [Related]
19. Tumor epitope spreading by a novel multivalent therapeutic cellular vaccine targeting cancer antigens to invariant NKT-triggered dendritic cells
Yamasaki S; Shimizu K; Fujii SI
Front Immunol; 2024; 15():1345037. PubMed ID: 38361934
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of natural killer T cell-based immunotherapy for cancer.
Motohashi S; Nakayama T
Cancer Sci; 2008 Apr; 99(4):638-45. PubMed ID: 18294290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
